SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-21-000086
Filing Date
2021-05-06
Accepted
2021-05-06 16:40:46
Documents
97
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20210331.htm   iXBRL 10-Q 2252936
2 EX-10.1 exhibit101-collaborationan.htm EX-10.1 976287
3 EX-31.1 exhibit311-2021q1.htm EX-31.1 9818
4 EX-31.2 exhibit312-2021q1.htm EX-31.2 9843
5 EX-32.1 exhibit321-2021q1.htm EX-32.1 6363
  Complete submission text file 0001651308-21-000086.txt   10618097

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210331.xsd EX-101.SCH 74079
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20210331_cal.xml EX-101.CAL 111512
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20210331_def.xml EX-101.DEF 368307
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210331_lab.xml EX-101.LAB 766936
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210331_pre.xml EX-101.PRE 540697
11 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210331_htm.xml XML 1478213
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 21898544
SIC: 2834 Pharmaceutical Preparations